Animal feed enzyme extraction
US-2015361478-A1 · Dec 17, 2015 · US
US9951371B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9951371-B2 |
| Application number | US-201514856251-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 16, 2015 |
| Priority date | Sep 17, 2014 |
| Publication date | Apr 24, 2018 |
| Grant date | Apr 24, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein is technology relating to the biological process of protein ubiquitination and particularly, but not exclusively, to compositions and methods for studying protein ubiquitination and developing therapeutics to modulate protein ubiquitination.
Opening claim text (preview).
We claim: 1. A composition comprising a ubiquitin C-terminal thioester fluorophore. comprises a ubiquitin covalently attached to a fluorophore by a thioester. 2. The composition of claim 1 wherein the ubiquitin C-terminal thioester fluorophore comprises a ubiquitin covalently attached to a linker and a linker covalently attached to the fluorophore. 3. The composition of claim 1 wherein the fluorophore is Fluorescein, Rhodamine, BODIPY, Alexa Fluor 488, Oregon Green 488, or Alexa Fluor 594. 4. The composition of claim 2 wherein the linker is an alkyl, cycloalkyl, aryl, heteroaryl, heteroalkyl polymer, carbon nanotube, quantum dot, or nanoparticle. 5. The composition of claim 1 wherein the ubiquitin comprises amino acids 1-76 of the ubiquitin polypeptide (SEQ ID NO: 1). 6. The composition of claim 1 further comprising an E3 ligase. 7. The composition of claim 6 wherein the E3 ligase is NEDD4, NEDD4L, ITCH, WWP1, WWP2, SMURF1, SMURF2, NEDL1, NEDL2, E6AP, HECTD2, KIAA0614, TRIP12, G2E3, EDD, HACE1, HECTD1, UBE3B, UBE3C, KIAA0317, HUWE1, HECTD3, HERC1, HERC2, HERC3, HERC4, HERC5, HERC6, SopA, NleL, ARIH1, ARIH2, CUL9, ANKIB1, PARK2, RNF144A, RNF144B, RBCK1, RNF19A, RNF19B, RNF31, RNF216, RNF14, RNF217, or a NEL E3 ligase. 8. The composition of claim 6 further comprising free fluorophore. 9. The composition of claim 6 further comprising activated E3˜Ub thioester.
with steric inhibition or signal modification, e.g. fluorescent quenching · CPC title
involving enzymes not classifiable in groups C12Q1/26 {- C12Q1/66} · CPC title
Ligases (6) · CPC title
Ubiquitin-protein ligase (6.3.2.19), i.e. ubiquitin-conjugating enzyme · CPC title
from mammals · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.